Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases

• Published in: Gastroenterology (New York, N.Y. 1943) Vol. 160; no. 3; pp. 677 - 689
• Main Authors: Barnes, Edward L., Loftus, Edward V., Kappelman, Michael D.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2021
• Subjects: Access to Care; Disparities; Environmental Exposures; Health Equity; Access to Care; AA; CD; Environmental Exposures; Disparities; IBD; Health Equity; PRO; SHARE; TNF; UC; ED
• ISSN: 0016-5085; 1528-0012; 1528-0012
• DOI: 10.1053/j.gastro.2020.08.064

Although Crohn’s disease (CD) and ulcerative colitis (UC) have been considered as disorders that affect individuals of European ancestry, the epidemiology of the inflammatory bowel diseases (IBDs) is changing. Coupled with the increasing incidence of IBD in previously low-incidence areas, the population demographics of IBD in the United States are also changing, with increases among non-White races and ethnicities. It is therefore important to fully understand the epidemiology and progression of IBD in different racial and ethnic groups, and the effects of race and ethnicity on access to care, use of resources, and disease-related outcomes. We review differences in IBD development and progression among patients of different races and ethnicities, discussing the effects of factors such as access to care, delays in diagnosis, and health and disease perception on disparities in IBD care and outcomes. We identify research priorities for improving health equity among minority patients with IBD.